drugset / Trial / NCT00930566

Extracorporal Photopheresis Pilot Study

NCT00930566

Phase 1/2 Unknown 20 enrolled Hospices Civils de Lyon
NaSingle-groupOpen-labelPrevention

Summary

ECP will be given to the patients \[UVAR®XTS TM Therakos system, Johnson \& Johnson\] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allowed it: 2 ECP per week the first 2 weeks, and 1 ECP per week during 1 month. Total = 8 ECP after transplantation.

Timeline

Start
2009-04
Primary completion
2011-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxsalen Other / unclassified Other